MedTrace Logo

Efficacy Trial for the Reduction of Glabellar Lines

NCT02466178 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2017-03-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ability of the Serene RF System to effectively improve the appearance of dynamic glabellar lines and sustain the effect for a minimum of 3 months.

Conditions

  • Rhytids in the Glabellar Region

Interventions

DEVICE

Serene RF System

The Serene RF System provides percutaneous delivery of radiofrequency (RF) energy to a targeted nerve.

Sponsors & Collaborators

  • Serene Medical Inc

    lead INDUSTRY

Principal Investigators

  • Scott McGill · Vice President Product Development

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-04-30
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02466178 on ClinicalTrials.gov